These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25862567)

  • 21. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
    Dai N; Bao Q; Lu A; Li J
    Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.
    Czyzewska J; Guzińska-Ustymowicz K; Ustymowicz M; Pryczynicz A; Kemona A
    Folia Histochem Cytobiol; 2010 Jan; 48(1):37-45. PubMed ID: 20529814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value.
    Schizas D; Moris D; Michalinos A; Kanavidis P; Oikonomou D; Papalampros A; Machairas A; Liakakos T
    J BUON; 2017; 22(2):383-389. PubMed ID: 28534359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
    Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
    Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas.
    Jung IM; Chung JK; Kim YA; Kim JE; Heo SC; Ahn YJ; Hwang KT; Kim BG; Lee KL; Kim CW; Kim WH; Chang MS
    J Korean Med Sci; 2007 Oct; 22(5):855-61. PubMed ID: 17982235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
    Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
    Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites.
    Mezi S; Chiappetta C; Carletti R; Nardini A; Cortesi E; Orsi E; Piesco G; Di Gioia C
    Head Neck; 2017 Sep; 39(9):1806-1818. PubMed ID: 28561907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cadherin 5 Is a Significant Risk Factor for Hematogenous Recurrence and a Prognostic Factor in Locally Advanced Gastric Cancer.
    Inokuchi M; Higuchi K; Takagi Y; Tanioka T; Nakagawa M; Gokita K; Okuno K; Kojima K
    Anticancer Res; 2017 Dec; 37(12):6807-6813. PubMed ID: 29187459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
    Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
    Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
    Zhou YN; Li M
    Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
    Ramesh S; Nash J; McCulloch PG
    Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer.
    Hong SA; Yoo SH; Lee HH; Sun S; Won HS; Kim O; Ko YH
    BMC Cancer; 2018 May; 18(1):506. PubMed ID: 29720122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer.
    Shen T; Zhang K; Siegal GP; Wei S
    Am J Clin Pathol; 2016 Nov; 146(5):603-610. PubMed ID: 27780797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
    Radulović P; Krušlin B
    Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.